Global Next Generation Cancer Diagnostics Market By Product Type (Liquid Biopsy, Genetic Testing, Next Generation Sequencing, Immunoassays, and Radiomics), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Leukemia), By End-user (Hospitals, Research Institutions, Laboratories, and Diagnostic Centers), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Feb 2025
- Report ID: 140727
- Number of Pages: 235
- Format:
-
keyboard_arrow_up
-
-
- Thermo Fisher Scientific Inc
- QIAGEN
- Novartis AG
- Illumina, Inc
- GE HealthCare
- Hoffmann-La Roche Ltd
- Agilent Technologies, Inc
- Abbott
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible